CYP3A4 and hepatocellular carcinoma: Moreover, targeting oxidative metabolism, which is mediated by CYP3A4 in the initial step of sorafenib elimination in HCC cells, represents a promising approach to enhance the sensitivity of these cells to targeted agents (22, 23).